Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza B-Reference-Cited by-同舟云学术

Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza B

Published:2018-09-08 Issue:10 Volume:68 Page:1713-1717
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Cowling Benjamin J¹^ORCID,Lim Wey Wen¹,Perera Ranawaka A P M¹,Fang Vicky J¹,Leung Gabriel M¹,Peiris J S Malik¹,Tchetgen Tchetgen Eric J²

Affiliation:

1. World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China

2. Statistics Department, Wharton School, University of Pennsylvania, Philadelphia

Funder

Health and Medical Research Fund of the Food and Health Bureau of the Hong Kong SAR Government

National Institute of General Medical Sciences

Research Grants Council of the Hong Kong Special Administrative Region

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/68/10/1713/28543400/ciy759.pdf

Reference17 articles.

1. Survey of distribution of seasonal influenza vaccine doses in 201 countries (2004–2015): the 2003 World Health Assembly resolution on seasonal influenza vaccination coverage and the 2009 influenza pandemic have had very little impact on improving influenza control and pandemic preparedness;Palache;Vaccine,2017

2. Clinical effectiveness of split-virion versus subunit trivalent influenza vaccines in older adults;Talbot;Clin Infect Dis,2015

3. Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines: a review and meta-analysis of the literature;Beyer;Clin Drug Investig,1998

4. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses;Hobson;Journal of Hygiene,1972

5. Nomenclature for immune correlates of protection after vaccination;Plotkin;Clin Infect Dis,2012

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine;Drugs;2024-08-21

2. Neutralizing antibodies do not fully explain SARS-CoV-2 protective immunity;Nature Medicine;2024-08-06

3. The role of influenza Hemagglutination-Inhibition antibody as a vaccine mediator in children;Vaccine;2024-08

4. SARS-CoV-2 correlates of protection from infection against variants of concern;Nature Medicine;2024-07-26

5. Cold‐adapted influenza‐vectored RSV vaccine protects BALB/c mice and cotton rats from RSV challenge;Journal of Medical Virology;2024-07